Indication
Myopic Choroidal Neovascularisation
1 clinical trial
2 products
Clinical trial
Intravitreal Conbercept Injection in Patients With Myopic Choroidal NeovascularizationStatus: Completed, Estimated PCD: 2022-12-01
Product
3+PRNProduct
6+PRN1 clinical trial
2 products